Inventor · disambiguated record
Pablo E. Vivas-Mejia
Also filed as: VIVAS-MEJIA PABLO · VIVAS-MEJIA PABLO E
3 granted patents·4 pending applications·3 citations·filing 2015–2023
58Inventor score
Top patents by PatentIndex Score
7 records- 0178US9895312B2Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant ovarian cancerVIVAS MEJIA PABLO E·Filed 2015·Granted Feb 20, 2018·2 cites·2 claims
- 0276US10548842B2Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant ovarian cancerVIVAS MEJIA PABLO E·Filed 2018·Granted Feb 4, 2020·1 cites·22 claims
- 0361US11090266B2Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant ovarian cancerVIVAS MEJIA PABLO E·Filed 2020·Granted Aug 17, 2021·0 cites·11 claims
- 0459US2025073257A1Small molecule and sirna inhibitors against lipocalin-2UNIV PUERTO RICO·Filed 2022·Application pending·0 cites
- 0557US2025333733A1Novel targets against ovarian cancerUNIV PUERTO RICO·Filed 2023·Application pending·0 cites
- 0642US2021196750A1Liposomal-gold nanoparticles for drug delivery into the brainVIVAS MEJIA PABLO·Filed 2020·Application pending·0 cites
- 0735US2018193267A1Nanoliposomal formulation for targeting integrin-linked kinase (ilk) with small-interference rna and a method for treating ovarian cancerVIVAS MEJIA PABLO E·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Pablo E. Vivas-Mejia files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →